These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28384121)

  • 1. Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway.
    Xia Y; Zhang Q; Zhen Q; Zhao Y; Liu N; Li T; Hao Y; Zhang Y; Luo C; Wu X
    Oncotarget; 2017 Jun; 8(23):37783-37795. PubMed ID: 28384121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.
    Rouce RH; Shaim H; Sekine T; Weber G; Ballard B; Ku S; Barese C; Murali V; Wu MF; Liu H; Shpall EJ; Bollard CM; Rabin KR; Rezvani K
    Leukemia; 2016 Apr; 30(4):800-11. PubMed ID: 26621337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients.
    Wang X; Huang L; Wen X; Li D; Yang G; Zheng J
    In Vivo; 2024; 38(1):174-183. PubMed ID: 38148073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell-derived exosome-based cancer therapy: from biological roles to clinical significance and implications.
    Si C; Gao J; Ma X
    Mol Cancer; 2024 Jun; 23(1):134. PubMed ID: 38951879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?
    Razizadeh MH; Zafarani A; Taghavi-Farahabadi M; Khorramdelazad H; Minaeian S; Mahmoudi M
    Cell Commun Signal; 2023 Sep; 21(1):261. PubMed ID: 37749597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Cell Dysfunction In Human Bladder Cancer Is Caused By Tissue-Specific Suppression of SLAMF6 Signaling.
    Farkas AM; Tran MA; Youssef D; Balan S; Newman JH; Audenet F; Anastos H; Peros A; Ananthanarayanan A; Daza J; Gonzalez-Gugel E; Sadanala K; Theorell J; Galsky MD; Horowitz A; Sfakianos JP; Bhardwaj N
    bioRxiv; 2024 May; ():. PubMed ID: 38746459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA fingerprint of early-stage clear cell renal cell carcinoma identified in urinary exosomes by mRNA sequencing.
    Marek-Bukowiec K; Konieczny A; Ratajczyk K; Czapor-Irzabek H; Górniak A; Kowal P
    Pol Arch Intern Med; 2021 Jun; 131(6):582-585. PubMed ID: 34018710
    [No Abstract]   [Full Text] [Related]  

  • 8. Uptake Characterization of Tumor Cell-derived Exosomes by Natural Killer Cells.
    Huyan T; DU Y; Huang Q; Huang Q; Li Q
    Iran J Public Health; 2018 Jun; 47(6):803-813. PubMed ID: 30087865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells in the brain tumor microenvironment: Defining a new era in neuro-oncology.
    Fares J; Fares MY; Fares Y
    Surg Neurol Int; 2019; 10():43. PubMed ID: 31528381
    [No Abstract]   [Full Text] [Related]  

  • 10. What Fuels Natural Killers? Metabolism and NK Cell Responses.
    Gardiner CM; Finlay DK
    Front Immunol; 2017; 8():367. PubMed ID: 28421073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal microRNAs isolated from plasma of mesenteric veins linked to liver metastases in resected patients with colon cancer.
    Monzo M; Santasusagna S; Moreno I; Martinez F; Hernández R; Muñoz C; Castellano JJ; Moreno J; Navarro A
    Oncotarget; 2017 May; 8(19):30859-30869. PubMed ID: 28415718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers.
    Menard LC; Fischer P; Kakrecha B; Linsley PS; Wambre E; Liu MC; Rust BJ; Lee D; Penhallow B; Manjarrez Orduno N; Nadler SG
    Front Immunol; 2018; 9():2728. PubMed ID: 30534127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
    Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art.
    Hatami Z; Hashemi ZS; Eftekhary M; Amiri A; Karpisheh V; Nasrollahi K; Jafari R
    Cancer Cell Int; 2023 Aug; 23(1):157. PubMed ID: 37543612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells.
    Di Pace AL; Pelosi A; Fiore PF; Tumino N; Besi F; Quatrini L; Santopolo S; Vacca P; Moretta L
    Oncoimmunology; 2023; 12(1):2221081. PubMed ID: 37304055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances.
    Zhang E; Phan P; Zhao Z
    Acta Pharm Sin B; 2023 May; 13(5):1789-1827. PubMed ID: 37250173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities and challenges of natural killer cell-derived extracellular vesicles.
    Qi Y; Zhao X; Dong Y; Wang M; Wang J; Fan Z; Weng Q; Yu H; Li J
    Front Bioeng Biotechnol; 2023; 11():1122585. PubMed ID: 37064251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Immune Cell-derived Exosomes on Immune Response Initiation and Immune System Function.
    Tavasolian F; Hosseini AZ; Rashidi M; Soudi S; Abdollahi E; Momtazi-Borojeni AA; Sathyapalan T; Sahebkar A
    Curr Pharm Des; 2021; 27(2):197-205. PubMed ID: 33290196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.
    Mashouri L; Yousefi H; Aref AR; Ahadi AM; Molaei F; Alahari SK
    Mol Cancer; 2019 Apr; 18(1):75. PubMed ID: 30940145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-related lncRNA score: A value-based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma.
    Yang Z; Zhang X; Zhan N; Lin L; Zhang J; Peng L; Qiu T; Luo Y; Liu C; Pan C; Hu J; Ye Y; Jiang Z; Liu X; Sun M; Zhang Y
    Cancer Med; 2024 Jun; 13(11):e7308. PubMed ID: 38808948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.